Toxoplasma sporozoite genes that determine environmental resistance and invasion of host cells.
弓形虫子孢子基因决定宿主细胞的环境抵抗力和入侵。
基本信息
- 批准号:10507659
- 负责人:
- 金额:$ 22.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-24 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAttenuated VaccinesBiological AssayCellsCessation of lifeComplementCongenital AbnormalityCystCytoplasmDataDefectDesiccationDiseaseDisease OutbreaksDroughtsEmbryonic DevelopmentEnvironmentEpithelial CellsFecesFelis catusFetusFood SupplyFreezingGene ProteinsGenesGeneticHumanImmunocompromised HostIn VitroInfectionInfection preventionIngestionInvadedKnock-outLeadLifeLivestockMeatMusNamesOocystsOralOrganismParasitesPathologyPlayPregnant WomenProceduresProteinsResistanceRiskRoleSalineSerologySheepSourceSporozoitesTestingTissuesToxoplasmaToxoplasma gondiiToxoplasmosisVaccinationVaccine DesignVaccinesZoonosesabortionacute infectionattenuationbasecongenital infectionenvironmental stressorextracellularfoodbornefoodborne illnessgene productin vivointestinal epitheliumpathogenpreventstressortransmission processvaccine accessvaccine discovery
项目摘要
Project Summary
The parasite Toxoplasma gondii can cause severe disease in immunocompromised patients and fetuses and
is the second leading cause of foodborne deaths in the USA. Infection starts after ingestion of oocysts shed in
cat feces or after ingestion of meat contaminated with tissue cysts. Oocysts are extremely stable in the
environment, resistant to the most inactivation procedures, and highly infectious. Because livestock get
infected by sporozoites derived from oocysts, a vaccine based on sporozoites or sporozoite proteins could be
effective in protecting livestock and humans. Currently, the only vaccine available is a live attenuated vaccine
only approved for use in sheep. However, this vaccine has serious shortcomings as the genetic basis for the
attenuation is not known, which poses reversion risks, and it needs to be used immediately once produced
because it is based on live tachyzoites, which are not viable for long outside host cells. Despite being a critical
step for Toxoplasma transmission, sporozoites inside oocysts are under-studied, largely because they are not
cultivatable in vitro and difficult to access in vivo. There is, therefore, a critical need to identify sporozoite gene
products that are critical for its invasion of host cells, which could lead to the discovery of vaccine targets.
Furthermore, if the genetic basis for the extreme environmental resistance of sporozoites was known it might
be possible to exploit this to make other Toxoplasma life stages, such as tachyzoites, or other pathogens more
viable extracellularly, which could enhance the shelf-life of vaccines based on live parasites. Our overall
objectives are to identify Toxoplasma genes that are specifically involved in the environmental resistance and
infectivity of sporozoites. Our central hypotheses are that 1) sporozoite-specific micronemal proteins (MICs)
are critical for their invasion into host cells; 2) late embryogenesis abundant proteins (LEAs), which are known
to provide resistance to environmental stresses such as drought, high salinity, and freezing in a variety of
organisms, determine sporozoite resistance to environmental stressors. In our first aim we will determine the
role of LEAs in the protection of sporozoites against environmental stressors. In our second aim we will test the
hypothesis that MICs that are specifically expressed in sporozoites are involved in the invasion of host cells.
The identification of sporozoite genes that play a role in extracellular survival and attachment/invasion of host
cells, will pave the way for designing vaccines that can prevent Toxoplasma infection of humans and animals.
项目摘要
寄生虫弓形虫可导致免疫功能低下的患者和胎儿发生严重疾病,
是美国食源性死亡的第二大原因。感染开始后,摄入的卵囊脱落,
猫粪便或摄入被组织囊肿污染的肉类后。卵囊在体内极其稳定
环境,抵抗大多数灭活程序,并且具有高度传染性。因为牲畜
被来自卵囊的子孢子感染,基于子孢子或子孢子蛋白质的疫苗可以
有效地保护牲畜和人类。目前,唯一可用的疫苗是减毒活疫苗
只允许用于羊。然而,这种疫苗作为疫苗的遗传基础存在严重缺陷。
衰减是未知的,这会带来逆转风险,并且一旦生产就需要立即使用
因为它是基于活的速殖子,而速殖子在宿主细胞外不能存活很长时间。尽管是一个关键的
作为弓形虫传播的步骤,卵囊内的子孢子尚未得到充分研究,主要是因为它们不是
可在体外培养且难以在体内获得。因此,迫切需要鉴定子孢子基因,
这些产品对于其入侵宿主细胞至关重要,这可能导致发现疫苗靶点。
此外,如果子孢子极端环境抗性的遗传基础是已知的,
可能利用这一点使其他弓形虫生命阶段,如速殖子,或其他病原体更多
活的细胞外,这可以提高基于活寄生虫的疫苗的保质期。我们的整体
目的是鉴定弓形虫基因,这些基因特异性地参与环境抗性,
子孢子的感染性。我们的中心假设是:1)子孢子特异性微线蛋白(MIC)
对于它们侵入宿主细胞是关键的; 2)晚期胚胎发生丰富蛋白(LEA),其是已知的
提供对环境胁迫如干旱、高盐和冰冻的抗性,
微生物,确定子孢子对环境应激源的抗性。在我们的第一个目标中,我们将确定
LEA在保护子孢子免受环境压力中的作用。在我们的第二个目标中,我们将测试
假设在子孢子中特异性表达的MIC参与宿主细胞的侵袭。
子孢子在宿主细胞外存活和附着/入侵中的作用基因的鉴定
细胞,将为设计预防人类和动物弓形虫感染的疫苗铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEROEN SAEIJ其他文献
JEROEN SAEIJ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEROEN SAEIJ', 18)}}的其他基金
Genetic barcoding to track Toxoplasma cyst heterogeneity during brain colonization, reactivation, and drug treatment.
基因条形码可追踪脑部定植、重新激活和药物治疗过程中弓形虫囊肿的异质性。
- 批准号:
10545368 - 财政年份:2022
- 资助金额:
$ 22.95万 - 项目类别:
Genetic barcoding to track Toxoplasma cyst heterogeneity during brain colonization, reactivation, and drug treatment.
基因条形码可追踪弓形虫包囊在脑定植、重新激活和药物治疗过程中的异质性。
- 批准号:
10664008 - 财政年份:2022
- 资助金额:
$ 22.95万 - 项目类别:
Toxoplasma sporozoite genes that determine environmental resistance and invasion of host cells.
弓形虫子孢子基因决定宿主细胞的环境抵抗力和入侵。
- 批准号:
10628015 - 财政年份:2022
- 资助金额:
$ 22.95万 - 项目类别:
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
对营养敏感的弓形虫菌株进行合成致死性筛选,以鉴定介导慢性弓形虫感染中营养获取的新蛋白质。
- 批准号:
10010286 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
对营养敏感的弓形虫菌株进行合成致死性筛选,以鉴定介导慢性弓形虫感染中营养获取的新蛋白质。
- 批准号:
10097993 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Identification of Toxoplasma genes that mediate its colonization of the eye
鉴定介导其在眼睛定植的弓形虫基因
- 批准号:
10242167 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Identification of Toxoplasma genes that mediate its colonization of the eye
鉴定介导其在眼睛定植的弓形虫基因
- 批准号:
10040382 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
A serological test to determine strains associated with ocular toxoplasmosis
确定与眼弓形体病相关菌株的血清学测试
- 批准号:
8891026 - 财政年份:2015
- 资助金额:
$ 22.95万 - 项目类别:
A serological test to determine strains associated with occular toxoplasmosis
确定与眼弓形体病相关菌株的血清学测试
- 批准号:
9070589 - 财政年份:2015
- 资助金额:
$ 22.95万 - 项目类别:
相似海外基金
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant
Rational Design of live-attenuated vaccines for flaviviruses
黄病毒减毒活疫苗的合理设计
- 批准号:
10397675 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
- 批准号:
10027464 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
- 批准号:
10405637 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
- 批准号:
10188419 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Rapid generation and testing of live-attenuated vaccines against SARS-CoV-2
快速生成和测试 SARS-CoV-2 减毒活疫苗
- 批准号:
10184147 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
- 批准号:
10674134 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses
针对脑炎甲病毒的减毒活疫苗的知情方法
- 批准号:
10636632 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Live attenuated vaccines to prevent against disease caused by A. pleuropneumoniae
用于预防胸膜肺炎放线杆菌引起的疾病的减毒活疫苗
- 批准号:
BB/S000321/1 - 财政年份:2018
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant